Renata Libianto

840 total citations
28 papers, 430 citations indexed

About

Renata Libianto is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Renata Libianto has authored 28 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Endocrinology, Diabetes and Metabolism, 20 papers in Surgery and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Renata Libianto's work include Hormonal Regulation and Hypertension (20 papers), Adrenal and Paraganglionic Tumors (17 papers) and Adrenal Hormones and Disorders (11 papers). Renata Libianto is often cited by papers focused on Hormonal Regulation and Hypertension (20 papers), Adrenal and Paraganglionic Tumors (17 papers) and Adrenal Hormones and Disorders (11 papers). Renata Libianto collaborates with scholars based in Australia, United Kingdom and China. Renata Libianto's co-authors include Jun Yang, Peter J. Fuller, Elif I. Ekinci, Morag J. Young, Jimmy Shen, Stella May Gwini, Allan D. Struthers, Stuart D. Pringle, Li Wei and Anna Maria Choy and has published in prestigious journals such as Journal of the American College of Cardiology, The Journal of Clinical Endocrinology & Metabolism and Radiology.

In The Last Decade

Renata Libianto

27 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renata Libianto Australia 11 241 237 180 59 46 28 430
Pieralberto Visentin Italy 10 386 1.6× 248 1.0× 180 1.0× 43 0.7× 16 0.3× 15 563
Parin J. Patel United States 10 245 1.0× 86 0.4× 142 0.8× 28 0.5× 29 0.6× 34 403
Assen Goudev Bulgaria 9 260 1.1× 127 0.5× 110 0.6× 17 0.3× 30 0.7× 37 408
Toshiaki Ohkuma Australia 11 178 0.7× 146 0.6× 44 0.2× 24 0.4× 26 0.6× 14 368
E. Andrikou Greece 10 134 0.6× 99 0.4× 45 0.3× 32 0.5× 37 0.8× 24 276
Seung-Yun Cho South Korea 14 237 1.0× 94 0.4× 142 0.8× 63 1.1× 17 0.4× 19 473
Arjun Pandey Canada 10 232 1.0× 172 0.7× 71 0.4× 74 1.3× 41 0.9× 36 413
Mustafa Kanat Türkiye 12 90 0.4× 252 1.1× 88 0.5× 47 0.8× 72 1.6× 18 453
Gurushankar Govindarajan United States 12 204 0.8× 83 0.4× 59 0.3× 23 0.4× 81 1.8× 26 391
Paola Tamburrini Italy 5 277 1.1× 71 0.3× 51 0.3× 28 0.5× 28 0.6× 7 352

Countries citing papers authored by Renata Libianto

Since Specialization
Citations

This map shows the geographic impact of Renata Libianto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renata Libianto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renata Libianto more than expected).

Fields of papers citing papers by Renata Libianto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renata Libianto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renata Libianto. The network helps show where Renata Libianto may publish in the future.

Co-authorship network of co-authors of Renata Libianto

This figure shows the co-authorship network connecting the top 25 collaborators of Renata Libianto. A scholar is included among the top collaborators of Renata Libianto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renata Libianto. Renata Libianto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akram, Muhammad, et al.. (2025). Changes in PTH Across the Spectrum of Renin-independent Aldosteronism. The Journal of Clinical Endocrinology & Metabolism. 110(11). e3694–e3700.
2.
Shah, Sonali, Renata Libianto, Stella May Gwini, et al.. (2024). Prevalence and Characteristics of Low-renin Hypertension in a Primary Care Population. Journal of the Endocrine Society. 8(8). bvae113–bvae113. 4 indexed citations
3.
Yang, Jun, Josephine McCarthy, Sonali Shah, et al.. (2024). Challenges in Diagnosing and Managing the Spectrum of Primary Aldosteronism. Journal of the Endocrine Society. 8(7). bvae109–bvae109. 2 indexed citations
4.
Libianto, Renata, Michael Stowasser, Grant Russell, Peter J. Fuller, & Jun Yang. (2023). Improving Detection Rates for Primary Aldosteronism. Experimental and Clinical Endocrinology & Diabetes. 131(07/08). 402–408. 2 indexed citations
5.
Gwini, Stella May, Renata Libianto, Kay Weng Choy, et al.. (2022). Aldosterone, Renin, and Aldosterone-to-Renin Ratio Variability in Screening for Primary Aldosteronism. The Journal of Clinical Endocrinology & Metabolism. 108(1). 33–41. 24 indexed citations
6.
Gwini, Stella May, Renata Libianto, Genevieve Gabb, et al.. (2022). Risky business: a single-centre cross-sectional analysis of calculated cardiovascular risk in patients with primary aldosteronism and essential hypertension. BMJ Open. 12(11). e062406–e062406. 1 indexed citations
7.
Yang, Jun, Renata Libianto, Jimmy Shen, et al.. (2022). Impact of dedicated multidisciplinary service on patient selection and outcomes for surgical treatment of primary aldosteronism. Surgery. 172(6). 1682–1688. 2 indexed citations
8.
Libianto, Renata, et al.. (2022). Screening for primary aldosteronism in the diabetic population: a cohort study. Internal Medicine Journal. 53(5). 709–716. 4 indexed citations
9.
Yang, Jun, Renata Libianto, Kenneth K. Lau, et al.. (2022). Impact of Intraprocedural Sedation on Adrenal Vein Sampling without Corticotropin Stimulation. Radiology. 304(3). 716–718. 4 indexed citations
10.
Libianto, Renata, Jun Yang, & Peter J. Fuller. (2021). Adrenal disease: An update. Australian Journal of General Practice. 50(1-2). 9–14. 2 indexed citations
11.
Libianto, Renata, et al.. (2020). Impact of Victoria's first dedicated endocrine hypertension service on the pattern of primary aldosteronism diagnoses. Internal Medicine Journal. 51(8). 1255–1261. 10 indexed citations
12.
Libianto, Renata, Peter J. Fuller, Morag J. Young, & Jun Yang. (2020). Primary aldosteronism is a public health issue: challenges and opportunities. Journal of Human Hypertension. 34(7). 478–486. 29 indexed citations
13.
Libianto, Renata, Timothy M. E. Davis, & Elif I. Ekinci. (2020). Advances in type 2 diabetes therapy: a focus on cardiovascular and renal outcomes. The Medical Journal of Australia. 212(3). 133–139. 18 indexed citations
14.
Chee, Nicholas Yong Nian, Renata Libianto, Stella May Gwini, et al.. (2020). Utility of adrenocorticotropic hormone in adrenal vein sampling despite the occurrence of discordant lateralization. Clinical Endocrinology. 93(4). 394–403. 20 indexed citations
15.
Chen, Angela, John L. Moran, Renata Libianto, et al.. (2019). Effect of angiotensin II receptor blocker and salt supplementation on short-term blood pressure variability in type 2 diabetes. Journal of Human Hypertension. 34(2). 143–150. 2 indexed citations
16.
Libianto, Renata, Kathy H. C. Wu, Sophie Devery, & John A. Eisman. (2019). KBG syndrome presenting with brachydactyly type E. Bone. 123. 18–22. 5 indexed citations
17.
Libianto, Renata & Elif I. Ekinci. (2019). New Agents for the Treatment of Type 2 Diabetes. Critical Care Clinics. 35(2). 315–328. 11 indexed citations
18.
Libianto, Renata, et al.. (2018). Pathophysiological Links Between Diabetes and Blood Pressure. Canadian Journal of Cardiology. 34(5). 585–594. 38 indexed citations
19.
Nadir, M. Adnan, Li Wei, Douglas H.J. Elder, et al.. (2011). Impact of Renin-Angiotensin System Blockade Therapy on Outcome in Aortic Stenosis. Journal of the American College of Cardiology. 58(6). 570–576. 113 indexed citations
20.
Elder, Douglas H.J., Li Wei, Benjamin R. Szwejkowski, et al.. (2011). The Impact of Renin-Angiotensin-Aldosterone System Blockade on Heart Failure Outcomes and Mortality in Patients Identified to Have Aortic Regurgitation. Journal of the American College of Cardiology. 58(20). 2084–2091. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pieralberto Visentin Breakdown of academic impact, for papers by Parin J. Patel Breakdown of academic impact, for papers by Assen Goudev Breakdown of academic impact, for papers by Toshiaki Ohkuma Breakdown of academic impact, for papers by E. Andrikou Breakdown of academic impact, for papers by Seung-Yun Cho Breakdown of academic impact, for papers by Arjun Pandey Breakdown of academic impact, for papers by Mustafa Kanat Breakdown of academic impact, for papers by Gurushankar Govindarajan Breakdown of academic impact, for papers by Paola Tamburrini
Rankless by CCL
2026